Covid 19

Product Development built on in-house Research had always been Excel’s forte. Developing innovative processes and technologies and building scale in select products were the basis of innovation culture in the Company. The Company wishes to strengthen these qualities further and use them in a structured manner to drive future business growth. The existing R&D team is being strengthened further.

The company formed a multi-location cross functional task force to assess and respond to the many changes emerging due to covid – redesigning processes to better focus on health, safety, compliances with region specific regulations etc. design and implement safe practices to avoid workplace infection. We drafted SOPs in multiple languages, and employees were trained vigorously, and the full implementation was monitored by task force members to ensure high order of compliance. The focus of all these efforts was enhanced employee care, especially in the context of Covid-19 infections.

We envision a bright future for our nation and strive hard to achieve the same through syneToday, we are set to embark on a new phase of meaningful growth. We enjoy leadership position in certain technology platforms and market segments eg. Agrochemical intermediates and Phosphorous derivatives. We will continue to focus on and grow the agrochemical intermediates, pharmaceutical API and intermediates, polymer additives and specialty chemicals business through enhanced customer interactions. New product R&D backed by robust infrastructure and team will create new opportunities in the coming years.

We envision a bright future for our nation and strive hard to achieve the same through synergy, innovation and hard work in our chosen sphere. What we are at Excel Industries Limited today is a result of thousands of hands working together to build a company that serves the country in its growth and development